1. Lazarou J, Pomeranz B, Corey P. Incidence of adverse
drug reactions in hospitalized patients. JAMA. 1998;279:1200-1205.
2. Rabin R. Caution About Overuse of Antibiotics. Newsday.
Sept. 18, 2003.
2a. http://www.cdc.gov/drugresistance/community/
3. Calculations detailed in Unnecessary Surgery section,
from two sources: (13) http://hcup.ahrq.gov/HCUPnet.asp
and (71) US Congressional House Subcommittee Oversight Investigation.
Cost and Quality of Health Care: Unnecessary Surgery. Washington,
DC: Government Printing Office, 1976
4. Calculations from four sources, see Unnecessary Hospitalization
section: (13) http://hcup.ahrq.gov/HCUPnet.asp and (93)
Siu AL, Sonnenberg FA, Manning WG, Goldberg GA, Bloomfield
ES, Newhouse JP, Brook RH. Inappropriate use of hospitals
in a randomized trial of health insurance plans. NEJM. 1986
Nov 13;315(20):1259-66. and (94) Siu AL, Manning WG, Benjamin
B. Patient, provider and hospital characteristics associated
with inappropriate hospitalization. Am J Public Health.
1990 Oct;80(10):1253-6. and (95) Eriksen BO, Kristiansen
IS, Nord E, Pape JF, Almdahl SM, Hensrud A, Jaeger S. The
cost of inappropriate admissions: a study of health benefits
and resource utilization in a department of internal medicine.
J Intern Med. 1999 Oct;246(4):379-87.
5. National Vital Statistics Reports. Vol. 51, No. 5, March
14, 2003.
6. Thomas et al., 2000; Thomas et al., 1999. Institute
of Medicine.
7. Xakellis, G.C., R. Frantz and A. Lewis, Cost of Pressure
Ulcer Prevention in Long Term Care, JAGS, 43 - 5, May 1995.)
8. Barczak, C.A., R.I. Barnett, E.J. Childs, L.M. Bosley,
"Fourth National Pressure Ulcer Prevalence Survey",
Advances in Wound Care, 10- 4, Jul/Aug 1997
9. Weinstein RA. Nosocomial Infection Update. Special Issue.
Emerging Infectious Diseases. Vol 4 No. 3, July Sept 1998.
10. Forth Decennial International Conference on Nosocomial
and Healthcare-Associated Infections, Morbidity and Mortality
Weekly Report (MMWR), February 25, 2000, Vol. 49, No. 7,
p. 138.
11. Greene Burger S, Kayser-Jones J, Prince Bell J. Malnutrition
and Dehydration in Nursing Homes:Key Issues in Prevention
and Treatment. National Citizens' Coalition for Nursing
Home Reform. June 2000. http://www.cmwf.org/programs/elders/burger_mal_386.asp
12. Starfield B. Is US health really the best in the world?
JAMA. 2000 Jul 26;284(4):483-5. Starfield B. Deficiencies
in US medical care. JAMA. 2000 Nov 1;284(17):2184-5.
13. HCUPnet, Healthcare Cost and Utilization Project for
the Agency for Healthcare Research and Quality. http://www.ahrq.gov/data/hcup/hcupnet.htm,
http://hcup.ahrq.gov/HCUPnet.asp, http://hcup.ahrq.gov/HCUPnet.asp
14. Leape L. National Patient Safety Foundation Press Release.
Nationwide Poll on Patient Safety Oct 9, 1997 New York.
http://www.npsf.org/html/pressrel/finalgen.html
15. The Troubled Healthcare System in the U.S. The Society
of Actuaries: Health Benefit Systems Practice Advancement
Committee. Sept. 13, 2003. http://www.soa.org/
16. Leape LL. Error in medicine. JAMA. 1994 Dec 21;272(23):1851-7.
16a.Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR,
Lawthers AG, et al. Incidence of adverse events and negligence
in hospitalized patients. N Engl J Med 1991; 324: 370-376.)
17. Campbell EG, Weissman JS, Clarridge B, Yucel R, Causino
N, Blumenthal D. Characteristics of medical school faculty
members serving on institutional review boards: results
of a national survey. Acad Med. 2003 Aug;78(8):831-6.
18. Possible Conflict of Interest Within Medical Profession.
Aug. 15, 2003 HealthDayNews.
19. World Health Organization, Press Release Bulletin #9,
December 17, 2001.
20. Angell M. Is academic medicine for sale? N Engl J Med.
2000 May 18;342(20):1516-8.
21. McKenzie J. Conflict of Interest? Medical Journal Changes
Policy of Finding Independent Doctors. June 12, 2002. ABC
News.
22. Crossen C. Tainted Truth: The Manipulation of Fact
in America. 1996. Touchstone Books.
23. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD,
Servi D, Laffel G, Sweitzer BJ, Shea BF, Hallisey R, et
al. Incidence of adverse drug events and potential adverse
drug events. Implications for prevention. ADE Prevention
Study Group. JAMA. 1995 Jul 5;274(1):29-34.
24. Vincent C, Stanhope N, Crowley-Murphy M. Reasons for
not reporting adverse incidents: an empirical study. J Eval
Clin Pract. 1999 Feb;5(1):13-21.
25. Wald, H and Shojania, K. Incident Reporting in Making
Health Care Safer: A Critical Analysis of Patient Safety
Practices, Agency for Healthcare Research and Quality (AHRQ),
2001.
26. Grinfeld MJ. The Debate Over Medical Error Reporting.
Psychiatric Times, April 2000. Vol. XVII Issue 4.
27. King, G. III, & Hermodson, A. Peer reporting of
coworker wrongdoing: A qualitative analysis of observer
attitudes in the decision to report versus not report unethical
behavior. 2000 Journal of Applied Communication Research,
28, 309-329.
28. Gilman AG, Rall TW, Nies AS, Taylor P. Goodman and
Gilman's: The pharmacological Basis of Therapeutics. 1996
New York: Pergamon Press.
29. Kolata G. New York Times News Service. "Who cares
when our drugs fail?" (San Diego Union-Tribune, Wed,
Oct. 15, 1997: E-1,5.
30. Melmon KL, Morrelli HF, Hoffman BB, and Nierenberg
DW. Melmon and Morrelli's Clinical Pharmacology: Basic Principles
in Therapeutics (3rd edition). New York: McGraw-Hill, Inc.,
1993.
31. Moore TJ, Psaty BM, Furberg CD. "Time to act on
drug safety." JAMA, May 20, 1998, 279 (19):1571-3.
31a. Cullen DJ, Bates DW, Small SD, Cooper JB, Nemeskal
AR, Leape LL. "The incident reporting system does not
detect adverse drug events: a problem for quality improvement."
Joint Commission Journal on Quality Improvement, Oct. 1995,
21 (10): 541-8.
32. Bates DW. "Drugs and adverse drug reactions: how
worried should we be? JAMA, Apr 15, 1998, 279 (15): 1216-7.
33. Dickinson JG. Dickinson's FDA Review. March 2000; 7
(3):13-14.
34. Cohen JS. Overdose: The Case Against the Drug Companies.
2001, Tarcher-Putnum New York.
35. Stenson J. Few Residents Report Medical Errors, Survey
Finds. Reuters Health. Feb 21, 2003.
36. Henry J. Kaiser Family Foundation, Harvard School of
Public Health. Methodology: Fieldwork conducted by ICR -
International Communications Research, April 11-June 11,
2002.
37. Bond CA, Raehl CL, Franke T. Clinical pharmacy services,
hospital pharmacy staffing, and medication errors in United
States hospitals. Pharmacotherapy. 2002 Feb;22(2):134-47.
38. Barker KN, Flynn EA, Pepper GA, Bates DW, Mikeal RL.
Medication errors observed in 36 health care facilities.
Arch Intern Med. 2002 Sep 9;162(16):1897-903.
39. LaPointe NM, Jollis JG. Medication errors in hospitalized
cardiovascular patients. Arch Intern Med. 2003 Jun 23;163(12):1461-6.
40. Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates
DW. The incidence and severity of adverse events affecting
patients after discharge from the hospital. Ann Intern Med.
2003 Feb 4;138(3):161-7.
41. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson
J, Burdick E, Seger DL, Shu K, Federico F, Leape LL, Bates
DW. Adverse drug events in ambulatory care. N Engl J Med.
2003 Apr 17;348(16):1556-64.
42. Medication side effects strike 1-in-4 April 17, 2003,
Reuters
43. Vastag B. Pay attention: ritalin acts much like cocaine.
JAMA. 2001 Aug 22-29;286(8):905-6.
44. Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein
AM. Promotion of prescription drugs to consumers. N Engl
J Med. 2002 Feb 14;346(7):498-505.
45. Wolfe SM. Direct-to-consumer advertising--education
or emotion promotion? N Engl J Med. 2002 Feb 14;346(7):524-6.
46. Ibib.
47. GAO/PEMD 90-15 FDA DRUG Review: Postapproval Risks
1976-1985, page 3.
48. MSNBC July 11, 2003
49. Suh DC, Woodall BS, Shin SK, Hermes-De Santis ER. Clinical
and economic impact of adverse drug reactions in hospitalized
patients. Ann Pharmacother. 2000 Dec;34(12):1373-9.
50. Egger WA. Antibiotic Resistance: Unnatural Selection
in the Office and on the Farm. Wisconson Medical Journal.
Aug. 2002.
51. Nash DR, Harman J, Wald ER, Kelleher KJ. Antibiotic
prescribing by primary care physicians for children with
upper respiratory tract infections. Arch Pediatr Adolesc
Med. 2002 Nov;156(11):1114-9.
52. Schindler C, Krappweis J, Morgenstern I, Kirch W. Pharmacoepidemiol
Drug Saf. 2003 Mar;12(2):113-20.
53. Finkelstein JA, Stille C, Nordin J, Davis R, Raebel
MA, Roblin D, Go AS, Smith D, Johnson CC, Kleinman K, Chan
KA, Platt R. Reduction in antibiotic use among US children,
1996-2000. Pediatrics. 2003 Sep;112(3 Pt 1):620-7.
54. Linder JA, Stafford RS. Antibiotic treatment of adults
with sore throat by community primary care physicians: a
national survey, 1989-1999. JAMA. 2001 Sep 12;286(10):1181-6.
55. http://www.cdc.gov/drugresistance/community/
56. http://www.health.state.ok.us/program/cdd/ar/
57. http://www.librainitiative.com/en/ap/or/li_ap_or_op.html
58. Ohlsen K, Ternes T, Werner G, Wallner U, Loffler D,
Ziebuhr W, Witte W, Hacker J. Impact of antibiotics on conjugational
resistance gene transfer in Staphylococcus aureus in sewage.
Environ Microbiol. 2003 Aug;5(8):711-6.
59. Pawlowski S, Ternes T, Bonerz M, Kluczka T, van der
Burg B, Nau H, Erdinger L, Braunbeck T. Combined in situ
and in vitro assessment of the estrogenic activity of sewage
and surface water samples. Toxicol Sci. 2003 Sep;75(1):57-65.
Epub 2003 Jun 12.
60. Ternes TA, Stuber J, Herrmann N, McDowell D, Ried A,
Kampmann M, Teiser B. Ozonation: a tool for removal of pharmaceuticals,
contrast media and musk fragrances from wastewater? Water
Res. 2003 Apr;37(8):1976-82.
61. Ternes TA, Meisenheimer M, McDowell D, Sacher F, Brauch
HJ, Haist-Gulde B, Preuss G, Wilme U, Zulei-Seibert N. Removal
of pharmaceuticals during drinking water treatment. Environ
Sci Technol. 2002 Sep 1;36(17):3855-63.
62. Ternes T, Bonerz M, Schmidt T. Determination of neutral
pharmaceuticals in wastewater and rivers by liquid chromatography-electrospray
tandem mass spectrometry. J Chromatogr A. 2001 Dec 14;938(1-2):175-85.
63. Golet EM, Alder AC, Hartmann A, Ternes TA, Giger W.
Trace determination of fluoroquinolone antibacterial agents
in urban wastewater by solid-phase extraction and liquid
chromatography with fluorescence detection. Anal Chem. 2001
Aug 1;73(15):3632-8.
64. Daughton CG, Ternes TA. Pharmaceuticals and personal
care products in the environment: agents of subtle change?
Environ Health Perspect. 1999 Dec;107 Suppl 6:907-38. Review.
65. Hirsch R, Ternes T, Haberer K, Kratz KL. Occurrence
of antibiotics in the aquatic environment. Sci Total Environ.
1999 Jan 12;225(1-2):109-18.
66. Ternes TA, Stumpf M, Mueller J, Haberer K, Wilken RD,
Servos M. Behavior and occurrence of estrogens in municipal
sewage treatment plants - I. Investigations in Germany,
Canada and Brazil. Sci Total Environ. 1999 Jan 12;225(1-2):81-90.
67. Hirsch R, Ternes TA, Haberer K, Mehlich A, Ballwanz
F, Kratz KL. Determination of antibiotics in different water
compartments via liquid chromatography-electrospray tandem
mass spectrometry. J Chromatogr A. 1998 Jul 31;815(2):213-23.
68. Coste J, Hanotin C, Leutenegger E. Prescription of
non-steroidal anti-inflammatory agents and risk of iatrogenic
adverse effects: a survey of 1072 French general practitioners.
Therapie. 1995 May-Jun;50(3):265-70.
69. Kouyanou K, Pither CE, Wessely S. Iatrogenic factors
and chronic pain. Psychosom Med. 1997 Nov-Dec;59(6):597-604.
70. Abel U. Chemotherapy of advanced epithelial cancer--a
critical review. Biomed Pharmacother. 1992;46(10):439-52.
71. Schulman KA, Stadtmauer EA, Reed SD, Glick HA, Goldstein
LJ, Pines JM, Jackman JA, Suzuki S, Styler MJ, Crilley PA,
Klumpp TR, Mangan KF, Glick JH. Economic analysis of conventional-dose
chemotherapy compared with high-dose chemotherapy plus autologous
hematopoietic stem-cell transplantation for metastatic breast
cancer. Bone Marrow Transplant. 2003 Feb;31(3):205-10.
72. Kaufman, M. Washington Post, May 18, 2002; Page A01.
73. US Congressional House Subcommittee Oversight Investigation.
Cost and Quality of Health Care: Unnecessary Surgery. Washington,
DC: Government Printing Office, 1976. Cited in: McClelland
GB, Foundation for Chiropractic Education and Research.
Testimony to the Department of Veterans Affairs' Chiropractic
Advisory Committee. March 25, 2003. http://www.fcer.org/html/Research/VAtestimony.htm
74. Leape LL. Unnecessary surgery. Health Serv Res. 1989
Aug;24(3):351-407.
75. Testimony to the Department of Veterans Affairs' Chiropractic
Advisory Committee ; George B. McClelland, D.C., Foundation
for Chiropractic Education and Research: March 25, 2003.
http://www.fcer.org/html/Research/VAtestimony.htm
76. Coile RC Jr. Internet-driven surgery. Russ Coiles Health
Trends. 2003 Jun;15(8):2-4.
77. Guarner V. Unnecessary operations in the exercise of
surgery. A topic of our times with serious implications
in medical ethics. Gac Med Mex. 2000 Mar-Apr;136(2):183-8.
78. Rutkow IM. Surgical operations in the United States:
1979 to 1984. Surgery. 1987 Feb;101(2):192-200.
79. Rutkow IM. Surgical operations in the United States.
Then (1983) and now (1994). Arch Surg. 1997 Sep;132(9):983-90.
80. Linnemann MU, Bulow HH. Infections after insertion
of epidural catheters. Ugeskr Laeger. 1993 Jul 26;155(30):2350-2
81. Seres JL, Newman RI. Perspectives on surgical indications.
Implications for controls. Clin J Pain. 1989 Jun;5(2):131-6.
82. Chassin MR, Kosecoff J, Park RE, Winslow CM, Kahn KL,
Merrick NJ, Keesey J, Fink A, Solomon DH, Brook RH. Does
inappropriate use explain geographic variations in the use
of health care services? A study of three procedures. JAMA.
1987 Nov 13;258(18):2533-7.
